Drug therapy. Clinical Pharmacokinetics (first of two parts).

Clinical pharmacokinetics (second of two parts).

Drug therapy: antiplatelet therapy (second of two parts).

Dialytic therapy for irreversible uremia (first of two parts).

Clinical pharmacology of oral antidiabetic agents (first of two parts).

Histamine (first of two parts).

Myasthenia gravis (first of two parts).

Renal transplantation (first of two parts).

Lung defense mechanisms (first of two parts).

Polymyositis and dermatomyositis (first of two parts).

Bronchodilator therapy (second of two parts).

Drug therapy. Drug allergy (second of three parts).

Basic and clinical concepts related to vitamin D metabolism and action (first of two parts).

Enzymology of cancer cells (first of two parts).

Binding of drugs to serum albumin (first of two parts).

Germ-cell testicular cancer in adults (first of two parts).

Catecholamines and neurologic diseases (first of two parts).

Secretin, cholecystokinin and newer gastrointestinal hormones (first of two parts).

Nonosmolar factors affecting renal water excretion (first of two parts).

Drug interactions and clinical pharmacokinetics.

FIRST REPORTS OF CLINICAL PHARMACOKINETICS IN NIGERIA.

Vasodilator therapy of cardiac failure (second of two parts).

Comparative clinical pharmacokinetics of antibody-drug conjugates in first-in-human Phase 1 studies.

Clinical pharmacology of oral antidiabetic agents (second of two parts).

progesterone capsule in clinical development for menopausal hormone therapy.

Suggest Documents

Clinical pharmacokinetics (second of two parts).

Drug therapy: antiplatelet therapy (second of two parts).

Dialytic therapy for irreversible uremia (first of two parts).

Clinical pharmacology of oral antidiabetic agents (first of two parts).

Histamine (first of two parts).

Myasthenia gravis (first of two parts).

Renal transplantation (first of two parts).

Lung defense mechanisms (first of two parts).

Polymyositis and dermatomyositis (first of two parts).

Bronchodilator therapy (second of two parts).

Drug therapy. Drug allergy (second of three parts).

Basic and clinical concepts related to vitamin D metabolism and action (first of two parts).

Enzymology of cancer cells (first of two parts).

Binding of drugs to serum albumin (first of two parts).

Germ-cell testicular cancer in adults (first of two parts).

Catecholamines and neurologic diseases (first of two parts).

Secretin, cholecystokinin and newer gastrointestinal hormones (first of two parts).

Nonosmolar factors affecting renal water excretion (first of two parts).

Drug interactions and clinical pharmacokinetics.

FIRST REPORTS OF CLINICAL PHARMACOKINETICS IN NIGERIA.

Vasodilator therapy of cardiac failure (second of two parts).

Comparative clinical pharmacokinetics of antibody-drug conjugates in first-in-human Phase 1 studies.

Clinical pharmacology of oral antidiabetic agents (second of two parts).

progesterone capsule in clinical development for menopausal hormone therapy.

Drug therapy. Clinical Pharmacokinetics (first of two parts).

Recommend Documents

Follow Us